These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7005620)
21. Testosterone: use, misuse and abuse. Handelsman DJ Med J Aust; 2006 Oct; 185(8):436-9. PubMed ID: 17137434 [TBL] [Abstract][Full Text] [Related]
22. Male pubertal development and the role of androgen therapy. Richmond EJ; Rogol AD Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616 [TBL] [Abstract][Full Text] [Related]
23. Exogenous Androgens and Male Reproduction. Drobnis EZ; Nangia AK Adv Exp Med Biol; 2017; 1034():25-28. PubMed ID: 29256124 [TBL] [Abstract][Full Text] [Related]
28. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men. Dinsmore WW; Wyllie MG BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877 [TBL] [Abstract][Full Text] [Related]
29. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism. Kaminetsky JC; Moclair B; Hemani M; Sand M J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402 [TBL] [Abstract][Full Text] [Related]
30. Androgen replacement in men with hypogonadism and erectile dysfunction. Albrecht-Betancourt M; Hijazi RA; Cunningham GR Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093 [TBL] [Abstract][Full Text] [Related]
31. Safety and adverse effects of androgens: how to counsel patients. Basaria S; Dobs AS Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S25-32. PubMed ID: 15065635 [TBL] [Abstract][Full Text] [Related]
32. [Oxymetholone therapy in bone marrow insufficiency]. Kühböck J; Radjaby M Acta Med Austriaca; 1974; 3(1):89-93. PubMed ID: 4618715 [No Abstract] [Full Text] [Related]
34. Testosterone administration in older men. Matsumoto AM Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401 [TBL] [Abstract][Full Text] [Related]
35. 54-year-old man with breast cancer after prolonged testosterone therapy. Sorscher S Clin Adv Hematol Oncol; 2005 Sep; 3(9):713. PubMed ID: 16224445 [No Abstract] [Full Text] [Related]
36. Testosterone replacement in men. Beg S; Al-Khoury L; Cunningham GR Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278 [TBL] [Abstract][Full Text] [Related]
37. Assessment and management of male androgen disorders: an update. Chan I; Fui MN; Zajac JD; Grossmann M Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767 [TBL] [Abstract][Full Text] [Related]
38. Transdermal delivery of testosterone. Hadgraft J; Lane ME Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Belkoff L; Brock G; Carrara D; Neijber A; Ando M; Mitchel J Andrologia; 2018 Feb; 50(1):. PubMed ID: 28295450 [TBL] [Abstract][Full Text] [Related]